There are two key points regarding post vaccination heart issues that HART have been raising concerns about since early 2021.
- Myocarditis is attributable to injection not infection
- What has been diagnosed may represent wider harm that is yet to be properly measured
Data from multiple sources now concur on important points. However, there is data from England which appears contradictory.
The risk of myocarditis in this large cohort study was highest in young males after the second SARS-CoV-2 vaccine dose, and this risk should be balanced against the benefits of protecting against severe COVID-19 disease.
Scientists believe they have solved the mystery behind the extremely rare blood clots caused by the Oxford-AstraZeneca vaccine.
A team of international experts, involving researchers from AstraZeneca, say that in a very small number of cases, the vaccine can set off a chain reaction which leads to the body confusing its own blood platelets for fragments of virus.
Vaccines derived from chimpanzee adenovirus Y25 (ChAdOx1), human adenovirus type 26 (HAdV-D26), and human adenovirus type 5 (HAdV-C5) are critical in combatting the severe acute respiratory coronavirus 2 (SARS-CoV-2) pandemic. As part of the largest vaccination campaign in history, ultrarare side effects not seen in phase 3 trials, including thrombosis with thrombocytopenia syndrome (TTS), a rare condition resembling heparin-induced thrombocytopenia (HIT), have been observed. This study demonstrates that all three adenoviruses deployed as vaccination vectors versus SARS-CoV-2 bind to platelet factor 4 (PF4), a protein implicated in the pathogenesis of HIT. We have determined the structure of the ChAdOx1 viral vector and used it in state-of-the-art computational simulations to demonstrate an electrostatic interaction mechanism with PF4, which was confirmed experimentally by surface plasmon resonance. These data confirm that PF4 is capable of forming stable complexes with clinically relevant adenoviruses, an important step in unraveling the mechanisms underlying TTS.
At a glance
A woman has described how she had to learn how to talk again after she said she was left partially-paralysed due to the side effects of her Covid-19 vaccine.
Kerry Hurt, from Rotherham, suffered a stroke after undergoing surgery for a blood clot two weeks after having the AstraZeneca jab.
The public is being threatened by the government…It doesn’t leave much room in their direction of travel…Look to Austrailia
The real-world study includes data on positive Covid PCR test results between May and July 2021 among more than a million people who had received two doses of Pfizer or AstraZeneca vaccine.
Protection after two shots of Pfizer decreased from 88% at one month to 74% at five to six months.
For AstraZeneca, the fall was from 77% to 67% at four to five months.
- Google Ventures’ investment in the AstraZeneca vaccine via Vaccitech.
- Reworking of the healthcare system and replacement of doctors with artificial intelligence.
- The ties between government, Big Tech, the military, healthcare and artificial intelligence.
- The AstraZeneca-Oxford vaccine is not non-profit. The two developers at the Jenner Institute, Sarah Gilbert and Adrian Hill, have a company, Vaccitech, on which the technology is based.
- The British Government has directly invested in Vaccitech and is expected a profit.
- The other main stakeholder is Bravos Capital (through Oxford Science Innovation), which was set up by former head of Global Equity Trading at Deutsche Bank.
- The German Government has invested money in CureVac BioNTech vaccine. 20% of the shares is owned by the German Government.
- Sequoia Capital‘s Chinese Branch, Fosun Pharma and The Wellcome Trust (through Oxford Science Innovation) are also investors in Vaccitech.
- The Wellcome Trust is the institution that is most involved in the AstraZeneca vaccine.
- The Jenner Institute is conducting trials in Africa for a universal malaria vaccine and they have a nasty track-record of not being honest about their trials. They lied about risks and infants died.
- The Jenner Institute was a public-private partnership with GlaxoSmithKline and the UK Government in the 1990s. They are one of the main vehicles at Oxford University for vaccine development and also UK vaccine funding research.
- Adrian Hill, the head of the Jenner Institute, is the chief at the UK Government’s UK Vaccine Network which decides which technology to research, fund and give to the population both in the UK and globally through vaccine philanthropy.
- COVAX, The Bill & Melinda Gates Foundation effort to vaccinate the developing world, relies almost entirely on AstraZeneca.
- Johnson & Johnson is being manufactured by Emergent BioSolutions which previously was called BioPort.
- BioPort was a spin-off of a fusion between Porton Down, the UK’s bio-defence lab (Defence Science and Technology Laboratory), and the between [William_J._Crowe] the former head of the Joint Chiefs of Staff under US President Ronald Regan.
- Emergent BioSolutions/BioPort was chosen to manufacture the Johnson & Johnson vaccine despite many scandals.
- The person in-charge of quality control for the Johnson & Johnson vaccine has no experience in the field. His background is head of Military Intelligence teams for the US Military in Iraq and Afghanistan and is also an expert on Iran and North Korea.
- Emergent BioSolutions are intimately connected to the CIA and Bechtel Corporation which has ties to the anthrax attacks in the US.
- Dr. Wodarg raised the possibility that the current situation is being used to covertly study wide use mRNA vaccines.
- Pfizer and Moderna mRNA technology was started with significant investment from DARPA in 2013.
- In 2016, Moderna was the most highly valued biotech company in the US but had no products.
- Regina Dugan greenlighted the investments from DARPA and later left in 2012 to create a DARPA-equivalent for Google and Facebook. She has now teamed up with the Wellcome Trust to create a ‘global health DARPA-equivalent’.
- Some discussion on the pre-911 anthrax vaccine and anthrax attack scandal, with links to reporter Judith Miller who was later involved in the Dark Winter simulation in June 2001.
- A lot of the same people who produced the Dark Winter simulation are the same people who oversaw Event 201 simulation.
- Dr. Wodarg raised concerns about the experimentation with lipid nanoparticles.
- There is a clear push to ‘remake healthcare’ from Silicon Valley towards AI healthcare and Precision Medicine, which is medications, vaccines and gene therapy targeted to the individual.
- A lot of COVID-19 testing in the Western US has been done by Google subsidiary Verily Life Sciences.
- AI healthcare and Precision Medicine is being co-developed by Google and the US military’s Defense Innovation Unit.
- Dr. Wodarg observed that we are seeing the unveiling of a long developed strategy.
- The push in medicine for gene editing goes back to Julian Huxley, first Director General of UNESCO and former president of the British Eugenics Society (renamed in 1989 to the Galton Institute). Julian Huxley, brother of Aldous Huxley, said in 1946 that we should, “make the unthinkable thinkable again” and also coined the term Transumanism. He said that gene editing as a eugenics science needed to be applied along with efforts to merge humans with machines in order to create a ‘new human being’. This goes back to 1957.
- Adrian Hill of the AstraZeneca vaccine spoke at the Galton Institute’s 100 Year Anniversary. The Wellcome Trust hosts their archive.
- Julian Huxley’s speech about “making the unthinkable thinkable again” was in connection with the founding of UNESCO.
- The push for Precision Medicine is ultimately about control and eugenics.
- The Obama Administration funded a lot of the Precision Medicine initiatives. The Biden Administration is creating a ‘health DARPA’ which will be led by Eric Lander (who has ties with Jeffrey Epstein).
- Jeffrey Epstein wanted the seed the human race with his own DNA. The scientists Epstein funded are still around. One of them is Harvard genetecist George Church who has openly promoted unethical human experimentation and eugenics.
- The Edge Foundation was operating as a front for Epstein as a way to gain influence in Silicon Valley, science and academia. His main handler is probably the Mega Group. He has ties with Isabelle Maxwell (Gislane Maxwell’s sister) who is a World Economic Forum technology pioneer.
- Bill Gates‘ ties with Epstein looks to go back to the 1990s. A 2001 Evening Standard article claims that Epstein’s main business partners were Leslie Wexner, Donald Trump and Bill Gates. Microsoft as a company may have been compromised by the same intelligence networks that Epstein operated in.
- Yuval Noah Harari: soon there will be an age of digital dictators and humans have been reduced to ‘hackable animals’ through technology.
- Klaus Schwab openly talks about COVID-19 being the catalyst for The Great Reset and Transhumanism. The fear of COVID would give way to the fear of Climate Change and Cyber Pandemic.
Conclusions: This lack of clear benefit should cause governments to rethink their vaccination policy.
The present assessment raises the question whether it would be necessary to rethink policies and use COVID-19 vaccines more sparingly and with some discretion only in those that are willing to accept the risk because they feel more at risk from the true infection than the mock infection. Perhaps it might be necessary to dampen the enthusiasm by sober facts? In our view, the EMA and national authorities should instigate a safety review into the safety database of COVID-19 vaccines and governments should carefully consider their policies in light of these data. Ideally, independent scientists should carry out thorough case reviews of the very severe cases, so that there can be evidence-based recommendations on who is likely to benefit from a SARS-CoV2 vaccination and who is in danger of suffering from side effects. Currently, our estimates show that we have to accept four fatal and 16 serious side effects per 100,000 vaccinations in order to save the lives of 2–11 individuals per 100,000 vaccinations, placing risks and benefits on the same order of magnitude.
Covid testing in schools is hugely disruptive and should be suspended, experts have said, as it emerged that up to 60 per cent of “positive” tests a week are coming back negative when checked.
Under plans to keep schools open, more than 50 million lateral flow tests have been carried out on youngsters, leading to thousands of pupils and their social bubbles being forced to self-isolate for 10 days.
Two embryonic cell lines have been used to develop COVID-19 vaccines: human embryonic kidney cells called HEK 293 and human embryonic retinal cells called PER.C6. The PER.C6 cell line is from an elective abortion in the Netherlands in 1985, and the HEK 293 cell line comes from an undisclosed source (either spontaneous miscarriage or elective abortion) in the Netherlands in about 1972.
Johnson & Johnson used PER.C6 cells in their COVID-19 vaccine development, and the Oxford/AstraZeneca vaccine used HEK 293 cells. CanSino Biologics and Gamaleya Research Institute’s Sputnik V vaccines have also used HEK 293 cells.
Moderna and Pfizer/BioNTech used HEK 293 cells in their proof-of-concept tests to see effectively take up the genetic instructions contained in these vaccines and produce the required spike protein. But human embryonic cell lines were not used to make either company’s final vaccine.
HEK 293 and PER.C6 cell lines have been genetically altered to include the part of the adenovirus instructions that trigger replication of adenoviruses. This allows the production of a large amount of the final vaccination product and allows the removal of the adenoviral replication instructions in the vaccine.
- Vaccine produced by a partnership between a University of Oxford research institute, Vaccitech, and AstraZeneca, does not need to be stored at freezing temperatures.
- Cheaper and easier to produce than the high-efficacy vaccines produced by BioNTech-Pfizer and Moderna.
- The price of AstraZeneca’s shares dropped on the news, and an analysis from an investment bank concluded, “We believe that this product will never be licensed in the US.”
- A closer look at the the Oxford-AstraZeneca trials reveals some very shaky science.
- Cherry-picked the data
- Dosing issues
- Opaque planning and data analysis procedures
- Age group selection
- Phase I clinical trials simply test the safety of a drug or vaccine in a small number of healthy volunteers — usually brave and naïve college students.
- Phase II trials are responsible for testing its effectiveness in a larger number of subjects.
- A hyped-up and exuberant response to a Phase I trial as seen with Moderna press release is rare and nearly unheard of.
- Little information is gleaned from an investigational drug in Phase I that has many more hurdles to overcome before it successfully gets to market
- 77 percent of vaccines for infectious diseases make it through Phase I, but only 33 percent make it through the entire process overall.
Moderna’s RNA vaccine
- Upon examining Moderna’s non-peer reviewed press release, the actual data on the vaccine’s success is even more flimsy.
- When it comes to finding out whether the vaccine elicits an antibody response that could potentially fight the coronavirus, they only had data on eight patients out of the 45 patients who received the vaccine.
- The only data Moderna mentioned when it comes to determining whether the vaccine was clinically effective against the coronavirus were from mice.
- History also proves that success in animal models is often not replicated in human studies.
- Moderna’s messenger RNA vaccine is completely new and revolutionary. Messenger RNA vaccines have never before been brought to market for human patients
- It uses a sequence of genetic RNA material produced in a lab that, when injected into your body, must invade your cells and hijack your cells’ protein-making machinery called ribosomes to produce the viral components that subsequently train your immune system to fight the virus.
- Some messenger RNA vaccines are self-amplifying. That means they can force the cell to replicate more copies of itself.
- There are unique and unknown risks to messenger RNA vaccines, including the possibility that they generate strong type I interferon responses that could lead to inflammation and autoimmune conditions.
Oxford Vaccine Group’s vaccine:
- Oxford Vaccine Group has a competing vaccine that does not need to invade and hijack our cells’ own machinery.
- From a medical and clinical perspective, there is less risk of generating a type I interferon response and autoimmunity because there is no messenger RNA floating around our blood, invading our cells.